Differential effects of cytotoxic drugs on mortal and immortalized B-lymphoblastoid cell lines from normal and Werner's syndrome patients

Biological & Pharmaceutical Bulletin
M OkadaM Sugimoto

Abstract

We studied the effects of nine cytotoxic drugs on three groups of B-lymphoblastoid cell lines transformed by Epstein-Barr virus (EBV): group 1, mortal cell lines from normal individuals; group 2, immortalized cell lines from normal individuals with strong telomerase activity; group 3, mortal cell lines from Werner's syndrome (WS) patients. Aminoglycoside antibiotics and alkylating drugs showed significantly stronger cytotoxic effects on immortalized cell lines than on mortal cell lines or the cell lines before immortalization. In contrast, topoisomerase II inhibitors showed no difference or they tended to be less cytotoxic to immortalized cell lines. Mortal cell lines from normal individuals and WS patients showed no difference in sensitivity against all the drugs examined except for the topoisomerase I inhibitor, camptothecin, which had a stronger cytotoxic effect on WS cell lines than other cell lines. We discuss the mechanisms underlying these cytotoxic effects.

Citations

Nov 16, 2001·Biochemical and Biophysical Research Communications·G KashinoM Watanabe
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·M Lebel, P Leder
May 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ruben AgreloManel Esteller
Dec 22, 1999·Nucleic Acids Research·M J MoserR J Monnat
Sep 21, 2002·Molecular and Cellular Biology·Yannick SaintignyRaymond J Monnat
Dec 17, 2008·Biogerontology·Dharmendra Kumar SinghVilhelm A Bohr
Sep 18, 2010·Journal of Nucleic Acids·Adam D BrownAlexander J R Bishop
Apr 27, 2000·Trends in Genetics : TIG·J C Shen, L A Loeb
Sep 1, 2004·Mechanisms of Ageing and Development·Lucio Comai, Baomin Li
Jun 26, 2001·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·S SakamotoA Shimamoto
Sep 14, 2000·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·J Oshima
Feb 24, 2001·American Journal of Medical Genetics·E CastroJ Oshima
May 5, 2006·Human Mutation·Shurong HuangJunko Oshima
Apr 29, 1999·Human Mutation·M J MoserR J Monnat
Jun 23, 1999·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·R K Chakraverty, I D Hickson
Feb 3, 2007·Aging Cell·Kiranjit K DhillonRaymond J Monnat
May 25, 2007·Aging Cell·Ramachander V N TuragaMichel Lebel
Oct 6, 2007·Biological & Pharmaceutical Bulletin·Kazunobu FutamiYasuhiro Furuichi
Jan 15, 2009·Apoptosis : an International Journal on Programmed Cell Death·Burkhard GreveTobias Bölling
Jul 6, 2005·Biological & Pharmaceutical Bulletin·Kaori SawadaMasanobu Sugimoto
Apr 27, 2007·Annals of the New York Academy of Sciences·Terence DavisDavid Kipling
Dec 21, 2013·International Journal of Molecular Medicine·Masanobu Sugimoto
Feb 13, 2002·Oncogene·Osamu ImamuraTakehisa Matsumoto
May 10, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M PootP S Rabinovitch
Jan 7, 2005·Biological & Pharmaceutical Bulletin·Kazunobu FutamiYasuhiro Furuichi
Oct 12, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·G BlanderM Oren
Apr 30, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Martin PootPeter S Rabinovitch
Jul 29, 2003·Aging Cell·Ana M Rodríguez-LópezLynne S Cox
Jul 27, 2000·Annals of the New York Academy of Sciences·J O NehlinV A Bohr
Apr 24, 2008·Mechanisms of Ageing and Development·Karen J OuyangNathan A Ellis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.